R&D expense · 2011–2025
Usana Health Sciences R&D expense
$10.7M−7.6% · FY2025
Usana Health Sciences (USNA) reported $10.7M in R&D expense for fiscal 2025, −7.6% year on year.
| Fiscal year | R&D expense | Change | Filing |
|---|---|---|---|
| FY20252026-01-03 | $10.7M | −7.6% | Open → |
| FY20242024-12-28 | $11.6M | +1.1% | Open → |
| FY20232023-12-30 | $11.4M | −1.0% | Open → |
| FY20222022-12-31 | $11.6M | +4.1% | Open → |
| FY20212022-01-01 | $11.1M | +4.5% | Open → |
| FY20202021-01-02 | $10.6M | +3.6% | Open → |
| FY20192019-12-28 | $10.3M | +0.2% | Open → |
| FY20182018-12-29 | $10.2M | +14.4% | Open → |
| FY20172017-12-30 | $9.0M | +1.2% | Open → |
| FY20162016-12-31 | $8.8M | +37.7% | Open → |
| FY20152016-01-02 | $6.4M | +25.2% | Open → |
| FY20142015-01-03 | $5.1M | +0.9% | Open → |
| FY20132013-12-28 | $5.1M | +9.0% | Open → |
| FY20122012-12-29 | $4.7M | +14.6% | Open → |
| FY20112011-12-31 | $4.1M | — | Open → |
R&D expense — Research and development expense is what the company charged to R&D in the income statement for the year. Most companies report no R&D at all — the line is absent rather than zero — so this ranking covers the roughly 40% of filers that do.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +7.1%
R&D expense at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Usana Health Sciences R&D expense |url=https://companiesranked.com/en/company/usana-health-sciences/research-and-development-expense |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Usana Health Sciences R&D expense. CompaniesRanked. https://companiesranked.com/en/company/usana-health-sciences/research-and-development-expenseBibTeX
@misc{companiesranked-en-company-usana-health-sciences-research-and-development-expense-2026,
author = {{CompaniesRanked}},
title = {{Usana Health Sciences R\&D expense}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/usana-health-sciences/research-and-development-expense}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0000896264-26-000021 · March 16, 2026
{{cite web |title=Usana Health Sciences R&D expense — 10-K (0000896264-26-000021) |url=https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/usna-20260103.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-03-16}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.